GSKCRISPRプラスミド
サンタクルスバイオテクノロジー社は遺伝子サイレンシング用のCRISPR/Cas9ノックアウト及びCRISPR Double Nickaseプラスミドを含め、広範囲の遺伝子編集製品を提供しております。GSK遺伝子サイレンサーは、GSK CRISPR/Cas9ノックアウトプラスミドとGSKDouble Nickaseプラスミドとして利用可能です。遺伝子活性化用のGSKCRISPR/dCas9 Activationプラスミド及びCRISPR Lenti Activationシステムも利用できます。遺伝子サイレンサーと活性化剤はタンパク質の検出に使用された抗体と組み合わせた遺伝子研究に有用です。
GSK CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
GSK-3α CRISPR/Cas9 KOプラスミド (h) | sc-400518 | h | Gene Knockout | GFP | 1 | ||
GSK-3α HDRプラスミド (h) | sc-400518-HDR | h | Homology Directed Repair | Puromycin | 1 | ||
GSK-3α Double Nickaseプラスミド (h) | sc-400518-NIC | h | Gene Knockout | Puromycin | 1 | ||
GSK-3α Double Nickaseプラスミド (h2) | sc-400518-NIC-2 | h | Gene Knockout | Puromycin | 1 | ||
GSK-3α CRISPR/Cas9 KOプラスミド (m) | sc-436875 | m | Gene Knockout | GFP | 0 | ||
GSK-3α HDRプラスミド (m) | sc-436875-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
GSK-3α Double Nickaseプラスミド (m) | sc-436875-NIC | m | Gene Knockout | Puromycin | 0 | ||
GSK-3α Double Nickaseプラスミド (m2) | sc-436875-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
GSK3 beta CRISPR/Cas9 KOプラスミド (h2) | sc-400090-KO-2 | h | Gene Knockout | GFP | 1 | ||
GSK3 beta HDRプラスミド (h2) | sc-400090-HDR-2 | h | Homology Directed Repair | Puromycin | 1 | ||
GSK3 beta Double Nickaseプラスミド (h) | sc-400090-NIC | h | Gene Knockout | Puromycin | 1 | ||
GSK3 beta Double Nickaseプラスミド (h2) | sc-400090-NIC-2 | h | Gene Knockout | Puromycin | 1 | ||
GSK3 beta CRISPR/Cas9 KOプラスミド (m) | sc-425249 | m | Gene Knockout | GFP | 2 | ||
GSK3 beta HDRプラスミド (m) | sc-425249-HDR | m | Homology Directed Repair | Puromycin | 2 | ||
GSK3 beta Double Nickaseプラスミド (m) | sc-425249-NIC | m | Gene Knockout | Puromycin | 2 | ||
GSK3 beta Double Nickaseプラスミド (m2) | sc-425249-NIC-2 | m | Gene Knockout | Puromycin | 2 |
GSK CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
GSK-3α CRISPR Activationプラスミド (h) | sc-400518-ACT | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
GSK-3α CRISPR Activationプラスミド (h2) | sc-400518-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
GSK-3α Lentiviral Activation Particles (h) | sc-400518-LAC | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
GSK-3α Lentiviral Activation Particles (h2) | sc-400518-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
GSK-3α CRISPR Activationプラスミド (m) | sc-436875-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
GSK-3α CRISPR Activationプラスミド (m2) | sc-436875-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
GSK-3α Lentiviral Activation Particles (m) | sc-436875-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
GSK-3α Lentiviral Activation Particles (m2) | sc-436875-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
GSK3 beta CRISPR Activationプラスミド (h) | sc-400090-ACT | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
GSK3 beta CRISPR Activationプラスミド (h2) | sc-400090-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
GSK3 beta Lentiviral Activation Particles (h) | sc-400090-LAC | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
GSK3 beta Lentiviral Activation Particles (h2) | sc-400090-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
GSK3 beta CRISPR Activationプラスミド (m) | sc-425249-ACT | m | Gene Activation | Puro, Blast, Hygro | 2 | ||
GSK3 beta CRISPR Activationプラスミド (m2) | sc-425249-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 2 | ||
GSK3 beta Lentiviral Activation Particles (m) | sc-425249-LAC | m | Gene Activation | Puro, Blast, Hygro | 2 | ||
GSK3 beta Lentiviral Activation Particles (m2) | sc-425249-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 2 |